secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acumen Pharmaceuticals, Inc. (ABOS)
CIK:        0001576885
Form:       8-K
Filed at:   2023-04-27T23:59:59+00:00
Accession:  0001193125-23-120000
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acumen adds BTIG as ATM sales agent; $4.25M of $50M capacity used as of April 26
--------------------------------------------------------------------------------

- Added BTIG, LLC as a sales agent under the existing at-the-market (ATM) offering agreement.
- Amendment to Sales Agreement dated July 1, 2022; prospectus remains for up to $50M in common stock.
- As of April 26, 2023, sold 422,160 shares for aggregate proceeds of approx. $4.25M.
- Shares offered through BofA Securities, Stifel, and now BTIG as sales agents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576885/000119312523120000/0001193125-23-120000-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576885/000119312523120000/d467609d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-120000

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer